The report “Prepacked Chromatography Columns Market by Type (1-100 mL, 100-1000 mL, >1L), by End User (Academic, Hospitals, Cosmetics, Environmental Biotechnology, Food & Beverages, Nutraceuticals, Pharmaceuticals), by Geography - Global Forecast to 2019”, this report studies the global prepacked chromatography columns market during the forecast period (2014-2019). The market is estimated at $1.42 Billion in 2014, and is projected to reach $2.11 Billion by 2019, at a CAGR of 8.4% from 2014 to 2019.
Dallas, TX -- (SBWIRE) -- 07/23/2015 -- Browse 29 market data tables and 29 figures spread through 75 pages and in-depth TOC on "Prepacked Chromatography Columns Market"
Early buyers will receive 10% customization on this report.
Pre-packed disposable column technology enables user specified inputs tailored to specific applications.
Rapid increase in the demand for biopharmaceutical products, in particular monoclonal antibodies (mAbs) and vaccines, over the years has led to the significant growth of the pre-packed chromatography columns market.
To advance disposable chromatography in the bioprocessing industry, a standard platform is required that can accommodate a wide variety of applications. Pre-packed columns find its applicability and demand in purification of proteins, biologic drug development for resin screening, sample preparation, protein purification, anion and cation exchange, de-salting and polish. Preparative pre-packed columns offer cost-effective and easy set-up, as well as requires less maintenance, especially in the purification of biological drugs and proteins.
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=231452946
Technological limitations of the column size are one of the major challenges faced by the prepacked chromatography columns market. The large-scale columns (45 cm–60 cm in diameter) are being highly commercialized and developed. The unavailability of prepacked columns beyond the 30 cm diameter size results in an upsurge in the overall demand for large scales columns. Currently, major players operating in the pre-packed chromatography columns market are highly focused on providing larger prepacked columns that provide technical, economic, and logistical advantages.
The global prepacked chromatography columns market is segmented on the basis of type, end user, and geography. Based on end user, the market is segmented into academics, nutraceuticals, food & beverages, hospitals, pharmaceuticals, cosmetics, and environmental biotechnology.
By geography, the global prepacked chromatography columns market is sub-divided into North America, Europe, Asia-Pacific, and rest of the world (RoW). In 2015, North America is estimated to dominate the global prepacked chromatography columns market, followed by Asia-Pacific and Europe. It is also the leading country occupying the highest share in the 1-100 mL segment of the global prepacked chromatography columns market.
Talk To Our Research Analysts for More Information:
With respect to type, the prepacked chromatography columns market covers types such as 1-100 ml, 100-1000 ml, and > 1L. Prepacked columns with more than 1L capacity occupy the largest share of 50% in this market. Today, as the cost of resins decreases and the viability of larger-sized column production increases, the large size industrial pre-packed columns are gaining popularity. The column size of more than 1L is having the largest market share in the total prepacked chromatography columns market. These will become increasingly popular with contract manufacturing organizations (CMOs) and clinical trial facilities, thus expanding the market as a whole.
Major players operating in the global prepacked chromatography columns market include GE Healthcare Lifesciences (U.S.), Atoll GMBH (Germany), EMD Millipore (U.S.), Phenomenex Inc. (U.S.), Agilent Technologies (U.S.), and PALL Corporation (U.S.) among others.
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets